How did TE's revenue and expenses trend in Q4 2024?

Teva Pharmaceutical Industries' (TE) revenue and expenses in Q4 2024 are not currently available. However, we can analyze the trends based on the available data.

1. **Revenue Trend**: The absence of specific revenue data for Q4 2024 makes it impossible to determine the revenue trend for that quarter. Please check the latest financial reports or news releases for the most recent information.
2. **Expense Trends**: Teva's Q4 2024 financials showed a significant decrease in net income, which was primarily driven by a substantial drop in operating expenses, particularly in the areas of financing expenses, asset impairment, depreciation, and amortization. The company's focus on cost control and restructuring efforts appears to have positively impacted its financial performance by reducing expenses and improving profitability.

|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|TE|TE.N|T1 Energy|2024 Q1|-122.35139114934512|-2.869E7|169|
|TE|TE.N|T1 Energy|2024 Q2|-6.920442467425107|-2.7161E7|169|
|TE|TE.N|T1 Energy|2024 Q3|-175.4498200719712|-2.7556E7|169|
|TE|TE.N|T1 Energy|2024 Q4|-1381.2676510933593|-3.67147E8|169|

|code|Ticker|Name|Date|Income Taxes|Income Taxes YoY|market_code|
|---|---|---|---|---|---|---|
|TE|TE.N|T1 Energy|2024 Q1|0|-100|169|
|TE|TE.N|T1 Energy|2024 Q2|11000|-92.02898550724638|169|
|TE|TE.N|T1 Energy|2024 Q4|-1.5771E7|-15561.764705882353|169|